Author

A. P. Glaser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

D. Fantini· 2 shared J. J. Meeks· 2 shared B. Lapin· 1 shared B. T. Helfand· 1 shared C.-H. Wang· 1 shared D. Baker· 1 shared E. T. Courtois· 1 shared G. M. Cresswell· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Fantini

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TNF Blockade Reduces Prostatic Hyperplasia and Inflammation while Limiting BPH Diagnosis in Patients with Autoimmune Disease

R. E. Vickman, L. Aaron-Brooks, R. Zhang, N. A. Lanman, B. Lapin, V. Gil, M. Greenberg, T. Sasaki, G. M. Cresswell, M. M. Broman, J. Petkewicz, P. Talaty, B. T. Helfand, A. P. Glaser, C.-H. Wang, , S. W. Hayward

Patient data and mouse models suggest that repurposing tumor necrosis factor alpha blockade reduces inflammation-mediated prostatic hyperplasia.

bioRxiv · Mar 11, 2021Cell Biology

Antibody Targeting of B7-H4 Enhances the Immune Response in Urothelial Carcinoma

J. R. Podojil, A. P. Glaser, D. Baker, E. T. Courtois, D. Fantini, Y. Yu, V. Eaton, S. Sivajothi, P. Robson, S. Miller, J. J. Meeks

This study identifies B7-H4 as a potential therapeutic target in bladder cancer, showing that anti-B7-H4 antibodies enhance immune responses and reduce tumor size in preclinical models.

bioRxiv · Aug 10, 2019Cancer Biology

APOBEC-Mediated Mutagenesis In Urothelial Carcinoma Is Associated With Improved Survival, Mutations In DNA Damage Response Genes, And Immune Response

A. P. Glaser, D. Fantini, K. J. Rimar, J. J. Meeks

The paper examines APOBEC-mediated mutagenesis in bladder cancer, finding it correlates with improved survival, mutations in DNA damage response genes, and immune response activation.

bioRxiv · Apr 4, 2017Cancer Biology